Drug-eluting stents in peripheral vascular disease: Eliminating restenosis

Mount Sinai Journal of Medicine

Volumn 70, Issue 6, 2003, Pages 417-419

  Ellozy, Sharif H ^a   Carroccio, Alfio ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Drug eluting stents; Peripheral artery occlusive disease; Restenosis

Indexed keywords

FK 506 BINDING PROTEIN; PROTEIN P27; RAPAMYCIN;

ANGIOPLASTY; ARTERY INTIMA PROLIFERATION; ARTERY OCCLUSION; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; DRUG ELUTING STENT; DRUG MECHANISM; DRUG PROTEIN BINDING; ENDOVASCULAR SURGERY; FEMORAL ARTERY; HUMAN; INHIBITION KINETICS; INTERMETHOD COMPARISON; MATERIAL COATING; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PERIPHERAL VASCULAR DISEASE; RESTENOSIS; REVIEW; SIDE EFFECT; THEORY; TREATMENT OUTCOME; VASCULAR PATENCY;

ANGIOGENESIS INHIBITORS; ANTI-INFLAMMATORY AGENTS; ARTERIAL OCCLUSIVE DISEASES; CORONARY RESTENOSIS; DRUG DELIVERY SYSTEMS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; PERIPHERAL VASCULAR DISEASES; PROSTHESIS DESIGN; RECURRENCE; SIROLIMUS; STENTS; VASCULAR PATENCY;

EID: 0347917147     PISSN: 00272507     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (8)

1. Bosch JL, Hunink MG. Meta-analysis of the results of percutaneous transluminal angioplasty and stent placement for aortoiliac occlusive disease. Radiology 1997; 204(1):87-96
2. Cejna M, Thurnher S, Illiasch H, et al. PTA versus Palmaz stent placement in femoropopliteal artery obstructions: a multicenter prospective randomized study. J Vasc Interv Radiol 2001; 12(1):23-31.
3. Muradin GS, Bosch JL, Stijnen T, Hunink MG. Balloon dilatation and stent implantation for treatment of femoropopliteal arterial disease: a meta-analysis. Radiology 2001; 221(1):137-145.
4. Poon M, Badimon JJ, Fuster V. Overcoming restenosis with sirolimus: from alphabet soup to clinical reality. Lancet 2002; 16:359(9306):619-622.
5. Klugherz D, Llanos G, Lieuallen W, et al. Twenty-eight-day efficacy and pharmacokinetics of the sirolimus-eluting stent. Coron Artery Dis 2002; 13(3):183-188.
6. Hwang CW, Wu D, Edelman ER. Physiological transport forces govern drug distribution for stent-based delivery. Circulation 2001; 104(5): 600-605.
7. Morice MC, Serruys PW, Sousa JE, et al. The RAVEL Study Group. A randomized comparison of a Sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002; 346:1773-1780.
8. Oliva VL. The SIRROCCO study - clinical investigation of the sirolimus coated Cordis SMART™ nitinol self-expandable stent for the treatment of obstructive superficial femoral artery disease. Cardiovascular research foundation symposium: enter the drug-eluting stent revolution, Atlanta, GA, March 16, 2002.